DELTEX

Trademark usage description

medical research and development; research and development of pharmaceuticals; research and development in the field of bioengineering and genetic eng Read More

Classification Information

Class [042]
Medical research and development; research and development of pharmaceuticals; research and development in the field of bioengineering and genetic engineering; research and development of treatments and therapies in the field of oncology; research and development of pharmaceuticals for the treatment and prevention of cancer, autoimmune, inflammatory, and infectious diseases and disorders; scientific research for medical purposes in the field of cancer, autoimmune, inflammatory, and infectious diseases and disorders; molecular, cellular, and genetic research and development; development of processes and methods for the manufacturing and engineering of cells and molecules; development of therapeutics and treatments for the prevention of cancer, autoimmune, inflammatory, genetic and infectious diseases and disorders

Classification kind code

Class [044]
Medical services; providing health information; providing health information in the field of bioengineering and genetic engineering; providing health information in the field of autoimmune, inflammatory and infectious diseases and disorders, cancer prevention and treatment; medical diagnosis and treatment of cancer, autoimmune, inflammatory, and infectious diseases and disorders; therapeutics and cell therapies for the treatment and prevention of cancer

Classification kind code

Mark Details

Serial Number

2131519

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 7^th Feb 2025	Agent Changed
Submitted for opposition 22 on 18^th Dec 2024	Search Recorded
Submitted for opposition 20 on 18^th Dec 2024	Examiner's First Report
Submitted for opposition 287 on 20^th May 2022	Pre-Assessment Letter Sent
Submitted for opposition 48 on 1^st Dec 2021	Agent Changed
Submitted for opposition 135 on 1^st Dec 2021	Amendment to Application
Submitted for opposition 30 on 3^rd Sept 2021	Filed
Submitted for opposition 1 on 3^rd Sept 2021	Created
Submitted for opposition 31 on 3^rd Sept 2021	Formalized